Rose Dugdale led an extraordinarily complex life which is captured in full by Sean O'Driscoll in his book. He talks to Dion Fanning about the good and the bad of the upper-class British woman turned IRA operative.
Thirty years ago, the Premier League began, developed from the frustrations of the big clubs. It has been an astonishing success story, which has brought its own problems for the sport.
An RTÉ legacy pension scheme generated returns equivalent to the public broadcaster’s entire commercial revenue last year – and is on course to grow a significant surplus into the future. But how?
Kieran Fitzpatrick and Maurice Curran built up Barracuda FX from scratch in the depths of the recession. So when the New York-based foreign exchange trading provider Broadway Technology moved in for a takeover, their pay day was assured. But just how much was due?
The value negotiated by the Irish founders of gym software firm Glofox for its acquisition by US-based ABC Fitness is a remarkable achievement for a company forced to retrench by Covid-19 just two years ago. Yet it is only a step on the journey now sketched out for the business.
Ian Browne, the entrepreneur and investor, is leading a fresh cohort of start-ups in the state-backed NDRC accelerator. He talks about steering founders through a stormy market and the need to for an all-Ireland ecosystem.
In the last two years, AIB has more than doubled and Bank of Ireland has more than tripled in value. First-half results now available for both institutions tell the story.
Timely restructuring shored up the finances of the group behind Fields and Fraser Hart jewellers just before the pandemic. A shareholder’s exit gives a glimpse of what its owners think it is worth now.
Tax and Brexit used to be at the top of the diplomatic agenda between Ireland and The Netherlands. Ambassador Adriaan Palm says environmental issues now take up most of his time, with Dutch companies targeting the new Irish offshore wind market.
With over 200 staff, the Co Cork pharmaceutical factory was among those sold off by Pfizer in 2020 to combine with Mylan and form Viatris. New information is available on its first year of trading within the new group.
© 2025 Currency Media Limited
